SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,055,000 | -81.2% | 290,983 | -77.2% | 0.03% | -82.1% |
| Q1 2017 | $80,065,000 | -30.5% | 1,273,698 | -41.7% | 0.16% | -34.7% |
| Q4 2016 | $115,195,000 | -48.0% | 2,182,971 | -46.8% | 0.24% | -45.8% |
| Q3 2016 | $221,675,000 | +30.4% | 4,104,329 | -2.4% | 0.44% | +22.2% |
| Q2 2016 | $169,969,000 | +10.8% | 4,206,104 | -3.8% | 0.36% | +13.2% |
| Q1 2016 | $153,426,000 | -22.0% | 4,372,346 | -0.2% | 0.32% | -17.6% |
| Q4 2015 | $196,667,000 | +47.1% | 4,382,053 | +26.4% | 0.39% | +42.3% |
| Q3 2015 | $133,692,000 | +38.0% | 3,467,125 | +73.2% | 0.27% | +52.0% |
| Q2 2015 | $96,905,000 | – | 2,002,164 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |